Anti–PD-1–Related Pneumonitis during Cancer Immunotherapy — NEJM Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Tuesday, August 04, 2015

Anti–PD-1–Related Pneumonitis during Cancer Immunotherapy — NEJM



Correspondence

 The clinical oncology community has rapidly expanding access to a variety of immunotherapeutic agents for the treatment of several types of cancers. Thus, knowledge of the spectrum of manifestations of autoimmune pneumonitis may assist other clinicians in managing this rare but potentially serious toxic effect.

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.